Metraipolis › archive › dc_c6221d8a33cd

A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma — Europe PMC PMID:42378032

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42378032
DOI
10.1172/jci.insight.192686
License (as archived)
solo-consultazione
Archived
2026-10-18T14:33:59.721Z
SHA-256 of the archived text
2a9767d6f75155b1180473582fdd9977ec6315b14dfcfcd1fb78d8a1af69e48a
Stable URL of this page
https://metraipolis.com/documento/dc_c6221d8a33cd

How to cite

A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma — Europe PMC PMID:42378032 — Europe PMC (en), https://europepmc.org/article/MED/42378032 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c6221d8a33cd (Metraipolis archive dc_c6221d8a33cd, sha256 2a9767d6f75155b1180473582fdd9977ec6315b14dfcfcd1fb78d8a1af69e48a)
BibTeX
@misc{dcc6221d8a33cd,
  title = {A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma — Europe PMC PMID:42378032},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42378032},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c6221d8a33cd; sha256 2a9767d6f75155b1180473582fdd9977ec6315b14dfcfcd1fb78d8a1af69e48a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42378032. Agents can read the archived copy with the MCP tool read_document.